(EXUS) Xtrackers MSCI World ex USA - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE0006WW1TQ4 • Global Large-Cap Blend Equity

EXUS: Shares, Large-Cap, Global, Ex-USA, Equity

The Xtrackers MSCI World ex USA UCITS ETF 1C USD (Ticker: EXUS) is a Germany-domiciled exchange-traded fund designed to track the performance of the MSCI World ex USA Index. This index includes large- and mid-cap companies across developed markets outside the United States, providing exposure to global equity markets while excluding U.S. stocks. The fund is listed on XETRA, a major European stock exchange, and is categorized as a Global Large-Cap Blend Equity ETF.

From a technical perspective, the ETF is currently trading at 30.90 EUR, with short-term momentum indicated by its SMA 20 of 29.28 and SMA 50 of 30.64. The SMA 200 stands at 30.23, suggesting a slightly bullish trend in the medium term. The Average True Range (ATR) of 0.66 indicates moderate volatility. Average daily trading volume over the past 20 days is 143,358 shares, reflecting reasonable liquidity for an ETF of its size.

Fundamentally, the ETF manages assets under management (AUM) of 1,500.23 million EUR, highlighting its popularity among investors seeking diversified exposure to global ex-U.S. equities. The funds structure allows it to capture growth opportunities in developed markets outside the United States, making it a strategic addition to portfolios seeking geographic diversification.

3-Month Forecast: Based on , the ETF is expected to maintain its upward trajectory in the near term, supported by the bullish crossover of its SMA 20 above the SMA 50. However, the SMA 200 at 30.23 may act as a resistance level, potentially capping sharp gains. The ATR of 0.66 suggests that price fluctuations will remain moderate, with an expected trading range between 29.50 and 32.50 EUR over the next three months.

From a perspective, the ETFs AUM of 1,500.23M EUR underscores its stability and investor confidence. The funds exposure to global ex-U.S. equities positions it to benefit from any rebound in international markets, particularly if the U.S. dollar weakens. However, geopolitical risks and potential earnings revisions in developed markets outside the U.S. could introduce volatility and impact performance.

Additional Sources for EXUS ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

EXUS ETF Overview

Market Cap in USD 1,697m
Category Global Large-Cap Blend Equity
IPO / Inception 2024-03-06

EXUS ETF Ratings

Growth Rating 37.0
Fundamental -
Dividend Rating 0.0
Rel. Strength -2.89
Analysts -
Fair Price Momentum 28.08 EUR
Fair Price DCF -

EXUS Dividends

No Dividends Paid

EXUS Growth Ratios

Growth Correlation 3m -77.1%
Growth Correlation 12m 64.5%
Growth Correlation 5y 72%
CAGR 5y 8.35%
CAGR/Max DD 5y 0.52
Sharpe Ratio 12m 0.80
Alpha -1.32
Beta 0.585
Volatility 10.42%
Current Volume 129.4k
Average Volume 20d 130.4k
What is the price of EXUS stocks?
As of May 12, 2025, the stock is trading at EUR 31.20 with a total of 129,354 shares traded.
Over the past week, the price has changed by +0.11%, over one month by +11.37%, over three months by -2.42% and over the past year by +6.38%.
Is Xtrackers MSCI World ex USA a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Xtrackers MSCI World ex USA (XETRA:EXUS) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 37.04 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EXUS as of May 2025 is 28.08. This means that EXUS is currently overvalued and has a potential downside of -10%.
Is EXUS a buy, sell or hold?
Xtrackers MSCI World ex USA has no consensus analysts rating.
What are the forecast for EXUS stock price target?
According to ValueRays Forecast Model, EXUS Xtrackers MSCI World ex USA will be worth about 31 in May 2026. The stock is currently trading at 31.20. This means that the stock has a potential downside of -0.61%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 31 -0.6%